CN102293786B - Medicinal composition for treating non-germ common cold - Google Patents
Medicinal composition for treating non-germ common cold Download PDFInfo
- Publication number
- CN102293786B CN102293786B CN2011102663918A CN201110266391A CN102293786B CN 102293786 B CN102293786 B CN 102293786B CN 2011102663918 A CN2011102663918 A CN 2011102663918A CN 201110266391 A CN201110266391 A CN 201110266391A CN 102293786 B CN102293786 B CN 102293786B
- Authority
- CN
- China
- Prior art keywords
- parts
- common cold
- germ
- vitamin
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a medicinal composition for treating non-germ common cold. The medicinal composition contains by weight: 62.5-3000 parts of analginum, 0.25-12 parts of chlortrimeton, 37.5-2700 parts of lactasin, 21.25-30 parts of vitamin B2 and 61.25-20 parts of vitamin B6. The non-germ common cold is the common multiple disease. The medicinal composition does not have toxic or side effect and medicine-resistant reaction. According to interaction of 'haemodynamics', 'microcirculation theory' and 'energy conservation rule', blood flow is smooth, the function of a digestive system is active, cells obtain sufficient nutrient, the immunologic function is improved, metabolism is promoted, brain nervous centralis is recovered to the normal adjusting function, respiratory center of medulla oblongata and center under cerebral cortex are recovered to relative balance state, and the effect of cotherapy is exerted completely, so that the best curative effect is achieved.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, especially relate to a kind of pharmaceutical composition for the treatment of non-germ common cold.
Background technology
To be that medical circle is universally recognized in the last hundred years caused by one or more pathogenic bacterias Common Cold.Be different from this conclusion, the inventor thinks through research and the clinical treatment of three more than ten years to this disease: Common Cold can be divided into without pathogenic bacteria and two types of pathogenic bacterias are arranged.
Aseptic Common Cold is owing under the body's immunity, disease had " susceptibility " causes, and central excitation under cerebral cortex, disease will occur during the regulatory function disequilibrium.Its pathogenic factor is that human body and external environment exist conflicting opposition:
The excitement of 1 nerve is uneven with inhibition, and " neuro humor circulation " theory confirms that Nervous and Mental Factors can make disease occur;
The suction of 2 air and the imbalance of breathing out, disease will occur when " medulla oblongata respiratory center " regulatory function is disorderly;
The generation of 3 body heats with distribute imbalance, when " thermotaxic centre " disequilibrium, disease will occur in the time of can not keeping normal function;
The new life of 4 cells and dead (metabolism) imbalance, " preservation of energy " when can not be guaranteed disease will occur;
In 5 foods absorption of nutrient substance with drain unevenly, the normal activity of gastrointestinal function is to be assimilated food in the middle nutrient substance input blood by intestinal villi, the colon classification excretes residue.If colon goblet cell secreting mucus is not enough, will make constipation; If unclean because of food, make escherichia coli active, a large amount of secreting mucus of goblet cell will be made diarrhoea, and this moment, disease will occur;
The stimulation of 6 materials is uneven with protection, causes anaphylaxis, and this moment will diseases.
Above-mentioned contradiction is under the brain central nervous system regulates, and is in relative dynamic equilibrium, can keep the normal physiological state just to be called health.
If dailyly do not note keeping the physiological status balance, work fatigue is not had a rest, and night life is excessive, poor sleep, and the mad food of carouseeing, satiety or starvation, malnutrition, gastrointestinal dysfunction will be directed at the fuselage state imbalance, immunologic hypofunction.At this moment, paathogenic factor acts on body, causes the struggle of infringement and anti-infringement.If infringement for the principal aspect of a contradiction, causes the dynamic disequilibrium of body and external environment and causes dysfunction, clinical symptoms, sign when the metabolism form changes, will occur, and affect the body growth growth, lose work capacity, will diseases.
Diagnosis: the multiple lower or temperature of temperature of being born in changes suddenly, and former suffer from allergic rhinitis, and this disease more easily occurs tonsillitis person.Auscultation pulmonary occurs without " moist rale ".
Clinical symptoms: onset begins that the sensation that nasopharynx part is dry, generate heat, itch is arranged, and nasal obstruction occurs subsequently, flows clear snot, and then dry cough occurs, hoarseness, fear of cold, fatigue, extremity and lumbago and backache, inappetence, constipation, idol has a headache, below the fervescence to 38.5 ℃.
Analyze: be still due to the disorderly out-of-balance condition of body regulatory function not pathogenic bacterium invasion this moment.Be 2-6 hour general incubation period.
The inventor once carried out bacteriology checking to the symptom occurring, only found " tubercule bacillus " (it has the cured film parcel of one deck, can survive for many years) in the sample of the spittle and dry expectorant dirt; From the sample of collecting gas, only see the withered bacteria breaking residue that lost efficacy, the virus of this trace and bacterial action are very weak in the ability of human body.They can only be survived in air 1-2 hour, can't invade for the human body of health.
For aseptic Common Cold, medical circle as there being the pathogenic bacteria invasion and attack to treat, does not only reach due therapeutic effect to it at present, has also fallen at the end patient's physical ability.Now be applied in the medicine in the treatment, use has no recovery from illness after one week more, and can repeatedly show effect.
And the Common Cold of pathogenic bacteria is arranged, refer to that pathogen is the influenza that influenza virus causes.Influenza virus makes a variation easily and produces new kind.
Two kinds of dissimilar synopsis of Common Cold
So the inventor is according to the curative mechanism of non-germ common cold, thinking needs exploitation can effectively treat the pharmaceutical composition of non-germ common cold.
Summary of the invention
The technical problem to be solved in the present invention provides a kind of pharmaceutical composition that can effectively treat non-germ common cold.
For solving the problems of the technologies described above the technical scheme that adopts: a kind of pharmaceutical composition for the treatment of non-germ common cold is characterized in that each weight portion proportioning of described pharmaceutical composition is: the quick 0.25-12 of dipyrone 62.5-3000, Piao Er, lactasinum 37.5-2700, vitamin B
21.25-30, vitamin B
61.25-20.
Dipyrone (Metamizole Sodium) belongs to antipyretic-antalgic and non_steroidal anti_inflammatory drug, can directly act on thermotaxic centre, makes cutaneous vasodilation, the blood flow acceleration, and perspiring increases, and heat radiation is accelerated and reduction body temperature.Dosage is 0.0625-3.0g every day.
Chlorphenamine (Chlorpheniramine) belongs to antihistaminic, has the irritated effect for the treatment of, with tranquilizer, hypnotic, when tranquilizer share, can deepen central inhibitory action, is used for the treatment of flu with APC aspirin phenacetin caffeine compatibility.Dosage is 0.25-12mg every day.
Lactasinum (Lactasin) is the enterococcal drying agent of living, and generates lactic acid at the intestinal degradation saccharide, and enteral acidity is increased, thereby suppresses the growth and breeding of putrefaction bacteria, and prevents the enteral fermentation, reduces aerogenesis, thereby facilitating digestion and anti-diarrhea effect are arranged.Dosage is 0.0375-2.7g every day.
Vitamin B
2(Vitamin B
2) be one of 13 kinds of vitamin of needed by human, as one of member of vitamin B complex, be the constituent of the important prothetic group of many enzyme systems in the body, participate in material and energy metabolism.Dosage is 1.25-30mg every day.
Vitamin B
6(Vitamin B
6) be the constituent of some coenzyme in the human body, participate in multiple metabolic response, especially with amino acid metabolism substantial connection is arranged.Dosage is 1.25-20mg every day.
Described pharmaceutical composition can be made into various oral formulations according to adding acceptable pharmaceutical necessities on the pharmaceutics.
Aseptic Common Cold is a kind of comparatively general multiple diseases, if with dipyrone, Piao Ermin, lactasinum, vitamin B
2, vitamin B
6Separately separately medication, without significant curative effect, but collaborative medication can be given full play to the effect of Synergistic treatment to aseptic Common Cold.To the Common Cold treatment without the pathogenic bacteria invasion, adopt medicine-dipyrone of regulating maincenter under the cerebral cortex, add Claritin-Piao Ermin, with energy ingredients-lactasinum, vitamin B
2, vitamin B
6Combination.The avirulence side effect of this kind pharmaceutical composition and drug resistance reaction, to cooperatively interact with the principle of " law of conservation of energy " according to " hemodynamics ", " microcirculation theory ", make blood flow unimpeded, digestive system function is active, and cell obtains sufficient nutrition, improves immunologic function, enhance metabolism, make the brain nervus centralis recover normal regulatory function, maincenter is returned to relative balance state under medulla oblongata respiratory center and the cerebral cortex, thereby reaches best therapeutic effect.
The specific embodiment
Pharmaceutical composition of the present invention is by dipyrone, Piao Ermin, lactasinum, vitamin B
2, vitamin B
6As main medicinal ingredient.The weight portion proportioning of each component is: 250 parts of dipyrones, 2 parts of chlorphenamines, 300 parts of lactasinums, vitamin B
210 parts, vitamin B
610 parts.Above-mentioned each component can be made into various oral formulations according to adding acceptable pharmaceutical necessities on the pharmaceutics.Such as capsule, can add 428 parts of starch, glue capsule technique is routinely made the capsule of every net weight 0.25g; Such as tablet, can add 428 parts of starch again, film-making agent technique is routinely made every net weight 0.25g tablet.
Therapeutic dose: the adult every day 1-2 time, every 8 hours once, can no longer take such as a produce effects each serving four (sheets); 7-12 year is each serving 1-2 grain (sheet); 2-6 year is each serving one (sheet); 6 months to one-year-old, each serving 1/2nd (sheets).For guaranteeing the safety of medication, take medicine first and need in 1/10 ratio examination clothes, after two hours, when determining that myxedema or exfoliative dermatitis reaction occur nothing, can use by normal therapeutic dosage.Drink more water generally 1-3 days transference cures after taking medicine.
For illustrating more fully beneficial effect of the present invention, the spy is illustrated pharmaceutical composition of the present invention with following clinical case for many years:
1, the daughter that adoptes of operation area, Guangzhou Mr. xxx, XXX, 1984 are begun by the baby, have Common Cold namely not take this agent in good time, and to present 2011,27 years old, oneself married and gave birth to babies, and serious symptom never occurs;
2, the abandoned baby that adoptes of certain xxx reporter of news unit is begun by the baby, has Common Cold namely not take this agent in good time, to present 2011, and 25 years old, graduate from university, serious symptom never occurs;
3, a Canadian nationality little girl who occupies Hong Kong, ten is one-year-old now, suffers from nasal obstruction, and snivel liquid generate heat 38 ℃, the power of extremity, appetite is not good enough, and the hospital therapy in Hong Kong does not show therapeutic effect after the week of having an injection, take medicine.Change under the author's guidance and take this agent once, cooperate high-energy diet and the rear transference cure of sufficient sleep, second day can carry out basketball movement, has no recurrence through the several months follow up survey;
4, the part teachers in primary and middle schools in somewhere, Guangdong use this agent and prevent and treat Common Cold for oneself and sons and daughters, and effect is excellent during the last ten years;
5, somewhere, Guangdong steel is practiced the several galvanizers of factory, electroplates material and the high-temperature gas that comes out because sucking, and makes nasal obstruction, snivel liquid, heating is more than 39 ℃, take this agent after, drink more water recovery from illness in three days.
Claims (2)
1. a pharmaceutical composition for the treatment of non-germ common cold is characterized in that each weight portion proportioning of described pharmaceutical composition is: the quick 0.25-12 of dipyrone 62.5-3000, Piao Er, lactasinum 37.5-2700, vitamin B
21.25-30, vitamin B
61.25-20.
2. a kind of pharmaceutical composition for the treatment of non-germ common cold as claimed in claim 1, it is characterized in that: described pharmaceutical composition is a kind of oral formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102663918A CN102293786B (en) | 2011-09-09 | 2011-09-09 | Medicinal composition for treating non-germ common cold |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102663918A CN102293786B (en) | 2011-09-09 | 2011-09-09 | Medicinal composition for treating non-germ common cold |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102293786A CN102293786A (en) | 2011-12-28 |
| CN102293786B true CN102293786B (en) | 2013-04-10 |
Family
ID=45354622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102663918A Expired - Fee Related CN102293786B (en) | 2011-09-09 | 2011-09-09 | Medicinal composition for treating non-germ common cold |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102293786B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101991632A (en) * | 2009-08-13 | 2011-03-30 | 望城县高塘岭镇赢声电的专利行 | Dropping liquid for treating cold |
-
2011
- 2011-09-09 CN CN2011102663918A patent/CN102293786B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101991632A (en) * | 2009-08-13 | 2011-03-30 | 望城县高塘岭镇赢声电的专利行 | Dropping liquid for treating cold |
Non-Patent Citations (2)
| Title |
|---|
| 抗感冒药的正确选择与合理应用;门曰利;《中国现代药物应用》;20090825;第3卷(第16期);95-96 * |
| 门曰利.抗感冒药的正确选择与合理应用.《中国现代药物应用》.2009,第3卷(第16期),95-96. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102293786A (en) | 2011-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988772B (en) | TCM (Traditional Chinese medicine) composition for treating infantile acute infantile convulsions and preparation method thereof | |
| CN104288727B (en) | A kind of dedicated compound Chinese medicinal preparation of chill cold in children health care | |
| CN103127430A (en) | Medicament for treating lower respiratory tract infection and preparation method thereof | |
| CN108619294A (en) | A kind of Chinese herbs paste for treating baby diarrhea | |
| CN102293786B (en) | Medicinal composition for treating non-germ common cold | |
| CN103721240B (en) | Compound formulation for treating bacterial infection of digestive tract of livestock and poultry and preparation method of compound formulation | |
| CN104758451A (en) | Traditional Chinese medicine composite for treating gout | |
| CN101507736A (en) | Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism | |
| CN101433329A (en) | Nutritive composition with health-care function | |
| CN104042951A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN104147261B (en) | A kind of Chinese medicine preparation for treating rheumatic arthritis | |
| CN103861051A (en) | Traditional Chinese medicine for treating stomachache | |
| CN105194658A (en) | Traditional Chinese medicinal preparation for treating obesity and enhancing physique and preparation method of traditional Chinese medicinal preparation | |
| CN111544410A (en) | Novel drug formula for immunotherapy and tablet structure thereof | |
| CN101023988A (en) | Chinese medicine preparation for treating infant's diarrhea | |
| CN106853013A (en) | Clovershrub navel is pasted | |
| CN100389676C (en) | Health-care food and its soft capsule for improving immunity of anti alimentary canal infection, and its prepn. method | |
| RU2772955C2 (en) | Human breast milk oligosaccharide mixture | |
| Karimi et al. | Childhood Asthma Treatment in a 12-year-old Boy according to Iranian Traditional Medicine in Tehran | |
| CN104958530A (en) | Traditional Chinese medicinal composition for treating infantile pneumonia | |
| CN104740620A (en) | Ant pill and application thereof | |
| Su | THERAPEUTIC SOLUTIONS FOR COVID | |
| Tabatabaeichehr et al. | The Effect of the Seed of Descurainia Sophia on Functional Constipation in Iranian Women Aged 50-70 Years: A Randomized Controlled Trial | |
| CN105106383B (en) | External traditional Chinese medicine for treating tourette syndrome | |
| CN103656086B (en) | The Chinese medicine preparation for the treatment of urarthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130410 Termination date: 20190909 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |